A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes.

@article{Plank2002ADC,
  title={A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes.},
  author={J. Plank and A. Wutte and Gernot Brunner and A. Siebenhofer and B. Semlitsch and R. Sommer and S. Hirschberger and T. Pieber},
  journal={Diabetes care},
  year={2002},
  volume={25 11},
  pages={
          2053-7
        }
}
OBJECTIVE Both rapid-acting insulin analogs, insulin aspart and lispro, attenuate prandial glucose excursion compared with human soluble insulin. This trial was performed to study the pharmacokinetic and pharmacodynamic profiles of insulin aspart and insulin lispro in type 1 diabetic patients in a direct comparison and to investigate whether the administration of one analog results in favorable effects on prandial blood glucose control. RESEARCH DESIGN AND METHODS A total of 24 type 1… Expand
139 Citations
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 36 REFERENCES
Pre‐meal Insulin Analogue Insulin Lispro vs Humulin® R Insulin Treatment in Young Subjects with Type 1 Diabetes
  • 91
Use of a novel double-antibody technique to describe the pharmacokinetics of rapid-acting insulin analogs.
  • 34
  • PDF
Post‐prandial administration of the insulin analogue insulin aspart in patients with Type 1 diabetes mellitus
  • 88
Time-action characteristics of regular and NPH insulin in insulin-treated diabetics.
  • 73
...
1
2
3
4
...